Abstract
The relatively recent emergence of antimicrobial resistance among several bacterial genera not only complicates the therapeutic management of infected patients,1 but also challenges laboratory testing practices and procedures. To effectively meet these challenges laboratorians must realize the important role they assume in the midst of this “resistance crisis” and re-evaluate their goals and responsibilities regarding provision of susceptibility data. In essence, we must focus this re-evaluation on three central issues regarding laboratory service:
-
Production of accurate and relevant susceptibility testing data
-
Surveillance of emerging resistance mechanisms and trends
-
Meaningful communication of results to physicians
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H.C. Neu, The crisis in antibiotic resistance, Science. 257: 1064 (1992).
M.B. Huang, T.E. Gay, C.N. Baker, S.N. Banerjee, and F.C. Tenover, Two percent sodium chloride is required for susceptibility testing of staphylococci with xacillin when using agar-based dilution methods, J. Clin. Microbiol. 31: 2683 (1993).
National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, NCCLS Approved Standard M7–A2 (1990).
National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial disk susceptibility tests, NCCLS Approved Standard M2 - A4 (1990).
M. Skulnick, A.E. Simor, D. Gregson, M. Patel, G.W. Small, B. Kreiswirth, D. Hathoway, and D.E. Low, Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus, J. Clin. Microbiol. 30: 1985 (1992).
J.L. Gerberding, C.Miick, H.H. Liu, and H.F. Chambers, Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus, Antimicrob. Agents Chemother. 35: 2574 (1991).
L.K. McDougal, and C. Thornsberry, the role of ß-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins, J. Clin. Microbial. 23: 832 (1986).
A. Tomasz, H.B. Drugeon, H.M. de Lencastre, D. Jabes, L. McDougal, and J. Bille, New mechanism for methicillin resistance in Staphylcoccus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity, Antimicrob. Agents Chemother. 33: 1899 (1989).
H.F. Chambers, G.L. Archer, and M.Matsuhashi, Low-level methicillin resistance of Staphyococcus aureus, Antimicrob. Agents Chemother. 33: 424 (1989).
R.M. Massanari, M.A. Pfaller, D.S. Wakesfield, G.T. Hammons, L.A. McNut, R.F. Woolson, and C.M. Helms, Implications of acquired oxacillin resistance in management and control of Staphylococcal aureus infections, J. Infect. Dis. 158: 702 (1988).
G.L. Archer, and E. Pennell, Detection of methicillin resistance in staphylococci by using a DNA probe, Antimicrob. Agents and Chemother. 34: 1720 (1990).
K. Murakami, W. Minamide, K. Wada, E. Nakamura, H. Teraoka, and S. Watanabe, Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction, J. Clin. Microbiol. 29: 2240 (1991).
R.C. Moellering, Jr., C. Wennersten, T. Medrek, and A.N. Weinberg, Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci, Antimicrob. Agents Chemother. p. 335 (1970).
D.F. Sahm, and C. Torres. Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis, J. Clin.Microbiol. 26: 250 (1988).
D.F. Sahm, and C. Torres, High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis, J. Clin. Microbiol. 26: 257 (1988).
D.F. Sahm, S. Boonlayangoor, P.C. Iwen, J.L. Baade, and G.L. Woods, Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis, J. Clin. Microbiol. 29: 1934 (1991).
C.A. Spiegel, Laboratory detection of high-level aminoglycoside-aminocyclitol resistance in Enterococcus spp., J. Clin. Microbiol. 26: 2270 (1988).
S. Szeto, M. Louie, D.E. Low, M. Patel, and A.E. Simor, Comparison of the new MicroScan Pos MIC Type 6 Panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species, J. Clin. Microbiol. 29: 1258 (1991).
D. Weissmann, J. Spargo, C. Wennersten, and M.J. Ferraro, Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive susceptibility cards, J. Clin. Microbiol. 29: 1232 (1991).
J.M. Swenson, M.J. Ferraro, D.F. Sahm, F.C. Tenover, and the Working Group on Enterococci, Recommended guidelines for detection of high-level aminoglycoside resistance in enterococci, Abstract 263, 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (1993).
A.H.C. Uttley, C.H. Collins, J. Naidou, and R.C. George, Vancomycin-resistant enterococci, Lancet i: 57 (1988).
R. Leclercq, E. Derlot, J. Duval, and P. Courvalin, Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium, N. Engl. J. Med. 319: 17 (1988).
D.F. Sahm, J. Kissinger, M.S. Gilmore, P.R. Murray, R. Mulder, J. Solliday, and B. Clarke, In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis, J. Clin. Microbiol. 33: 1588 (1989).
J.M. Swenson, B.C. Hill, and C. Thornsberry, Problems with the disk diffusion test for detection of vancomycin resistance in enterococci, J. Clin. Microbiol. 27: 2140 (1989).
D.F. Sahm, and L. Olsen, In vitro detection of enterococcal vancomycin resistance, Antimicrob. Agents Chemother. 34: 1846 (1990).
J.M. Swenson, M.J. Ferraro, D.F. Sahm, P. Charache, The Enterococcal Committee for Clinical Laboratory Standards Working Group on Enterococci, and F.C. Tenover, New vancomycin disk diffusion breakpoints for enterococci, J. Clin. Microbiol. 30: 2525 (1992).
National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial susceptibility testing, NCCLS supplement M100–S4 (1992).
F.C. Tenover, J. Tokars, J. Swenson, S. Paul, K. Spitalny, and W. Jarvis, Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci, J. Clin. Microbiol. 31: 1695 (1993).
B.D. Jett, A.S. Artz, L.K. Free, and D.F. Sahm, Heterogeneous expression and detection of van B-mediated vancomycin resistance in enterococci, Abstract 154, 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (1993).
B.M. Willey, B.N. Kreiswirth, A.E. Simor, G. Williams, S.R. Scriver, A. Phillips, and D.E. Low, Detection of vancomycin resistance in Enterococcus species, J. Clin. Microbiol. 30: 1621 (1992).
J.M. Swenson, N. Clark, M.J. Ferraro, D.F. Sahm, G. Doern, M.A. Pfaller, L.B. Reller, M. Weinstein, R.J. Zabransky, and F.C. Tenover, Screening enterococci for vancomycin resistance, J. Clin. Microbiol. In preparation (1994).
J.S. Bradley, and J.D. Connor, Ceftriaxone failure in meningitis caused by S. pneumoniae with reduced susceptibility to beta-lactam antibiotics, Pediatr. Infect. Dis. J. 10: 871 (1991).
A.M. Figueinedo, J.D. Connor, A. Severin, M. Vitoria Vaz Pato, and A. Tomasz, A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone, Antimicrob. Agents Chemother. 36: 886 (1992).
M.M. Sloas, F.F. Barrett, P.J. Chesney, B.K.English, B.C. Hill, F.C. Tenover, and R. Leggiadro, Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis, Pediatr. Infect. Dis. J. 11: 662 (1992).
J.H. Jorgensen, A.W. Howell, and L.A. Maher, Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test, J. Clin. Microbiol. 29: 109 (1991).
M.R. Jacobs, S. Bajaksouzian, P.C. Appelbaum, and A. Bolmstrom, Evaluation of the E-test for susceptibility testing of pneumococci, Diagn. Microbiol. Infect. Dis. 15: 474 (1992).
J.H. Jorgensen, J.M. Swenson, F.C. Tenover, M.J. Ferraro, J.A. Hindler, and P.R. Murray, Development of quality control and interpretive criteria for antimicrobial susceptibility testing of Streptococcus pneumoniae. Abstract 262, 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (1993).
G.A. Jacoby, and A.A. Medeiros, More extended-spectrum 3-lactamases, Antimicrob. Agents Chemother. 35: 1697 (1991).
T.G. Emori, and R.P. Gaynes, An overview of nosocomial infections, including the role of the microbiology laboratory, Clin. Microbiol. Rev. 6: 428 (1993).
K.S. Thomson, and C.C. Sanders, Detection of extended-spectrum 3-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three dimensional tests, Antimicrob. Agents Chemother. 36: 1877 (1992).
K.S. Meyer, C. Urban, J.A. Eagan, B.J. Berger, and J.J. Rahal, Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins, Ann. Intern. Med. 119: 353 (1993).
V. Jarlier, M. Nicolas, G. Fournier, and A. Philippon, Extended broad-spectrum 13-lactamases conferring transferrable resistance to newer 3-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns, Rev. Infect. Dis. 10: 867 (1988).
P. Courvalin, Interpretive reading of antimicrobial susceptibility tests, American Society for Microbiology News 58: 368 (1992).
J.P. Quinn, D. Miyashiro, D. Sahm, R. Flamm, and K. Bush, Novel plasmid-mediated 3-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae, Antimicrob. Agents Chemother. 33: 1451 (1989).
S. Evers, D.F. Sahm, and P. Courvalin, The uanB gene of vancomycin-resistant Enterococccus faecalis V583 is structurally related to genes encoding D-ala:D-ala ligases and glycopeptide-resistance proteins Van A and Van C, Gene 124: 143 (1993)
J.A. Hindler, and D.F. Sahm, Controversies and confusion regarding antimicrobial susceptibility testing of enterococci, Antimicrob. News1. 8: 65 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sahm, D.F. (1995). Emerging Trends in Antimicrobial Resistance: A Laboratory Perspective. In: Jungkind, D.L., Mortensen, J.E., Fraimow, H.S., Calandra, G.B. (eds) Antimicrobial Resistance. Advances in Experimental Medicine and Biology, vol 390. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9203-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9203-4_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9205-8
Online ISBN: 978-1-4757-9203-4
eBook Packages: Springer Book Archive